Experiments for taxon Citrus hassaku (RUTACEAE)

Experiments (109 results)

Filters
Worktypes (20)
50
37
35
30
29
28
27
22
21
21
7
6
5
2
2
1
1
1
1
1
No match
Pharmacology (25)
14
6
5
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
62
No match
Compounds (60)
12
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
27
No match
Organisms (36)
24
15
7
6
5
4
4
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
109 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
140949
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
FUROCOUMARIN,5-HYDROXY:
914612
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Citrus hassaku (RUTACEAE)
SYNEPHRINE
971816
PHARMACOLOGY OF EXTRACT - IN VIVO
ANAPHYLACTIC RESPONSE
Citrus hassaku (RUTACEAE)
1185210
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus hassaku (RUTACEAE)
AURAPTEN
1185209
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus hassaku (RUTACEAE)
AURAPTEN
971811
PHARMACOLOGY OF EXTRACT - IN VITRO
SMOOTH MUSCLE RELAXANT ACTIVITY
Citrus hassaku (RUTACEAE)
140934
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
COUMARIN,7-(3-7-DIMETHYL-6-OXO-OCT-TRANS-2-ENYL-OXY):
884760
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Citrus hassaku (RUTACEAE)
HESPERIDINNARIRUTINHESPERIDIN,NEO:NARINGIN
804829
PHARMACOLOGY OF EXTRACT - IN VITRO
CYTOCHROME P450 INHIBITION
Citrus hassaku (RUTACEAE)
119249
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
DENLETIN,NOR:
140945
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
MARMIN,6-O-(GERANYL-OXY-2-HYDROXY)-CINNAMOYL: (R):
1185207
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
AURAPTEN
152314
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
HASSANIN,CIS:
869550
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
AURAPTEN
646773
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Citrus hassaku (RUTACEAE)
124956
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
CITRUSARIN B
208022
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
KHELMARIN C
140952
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
FUROCOUMARIN,5-GERANYL-OXY:
141885
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
CITRUMARIN B
971819
PHARMACOLOGY OF EXTRACT - IN VITRO
SEROTONIN (5-HT) ANTAGONIST ACTIVITY
Citrus hassaku (RUTACEAE)
119252
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
SESELINOL
935863
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Citrus hassaku (RUTACEAE)
HESPERIDIN,NEO:
971817
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIHISTAMINE ACTIVITY
Citrus hassaku (RUTACEAE)
141884
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
CITRUMARIN C
935862
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Citrus hassaku (RUTACEAE)
NARINGIN
971815
PHARMACOLOGY OF EXTRACT - IN VITRO
CAPILLARY PERMEABILITY INCREASED
Citrus hassaku (RUTACEAE)
971808
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIASTHMATIC ACTIVITY
Citrus hassaku (RUTACEAE)
128624
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
MARMIN,6-O-(GERANYL-OXY-2-HYDROXY)-CINNAMOYL: (R):
422582
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTIOXIDANT ACTIVITY
Citrus hassaku (RUTACEAE)
971821
PHARMACOLOGY OF EXTRACT - IN VITRO
CHRONOTROPIC EFFECT POSITIVE
Citrus hassaku (RUTACEAE)
140939
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
COUMARIN,7-(3-7-DIMETHYL-6-HYDROXY-OCTA-TRANS-2-TRANS-7(9)-DIENYL-OXY):
855137
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Citrus hassaku (RUTACEAE)
LIMONENE
152311
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
ACRIMARINE C,NEO:
208023
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
HASSANIDIN,BIS:
148489
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
HASSMARIN
350191
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
AURAPTENE
152315
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
HASSANIN,TRANS:
140942
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
COUMARIN,7-(6(R)-FORMYL-OXY-7-HYDROXY-3-7-DIMETHYL-OCT-TRANS-2-ENYL-OXY):
140930
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
AURAPTEN
531240
ISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
HESPERIDINRHOIFOLINNARINGIN
183810
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
CLAUDIMERIN B
140941
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
COUMARIN,7-(6(R)-FORMYL-OXY-7-HYDROXY-3-7-DIMETHYL-OCT-TRANS-2-ENYL-OXY):
140946
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
MARMIN,6-O-(GERANYL-OXY-2-HYDROXY)-CINNAMOYL: (R):
601528
PHARMACOLOGY OF EXTRACT - IN VITRO
CYCLOOXYGENASE INHIBITION
Citrus hassaku (RUTACEAE)
140929
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
AURAPTEN
971820
PHARMACOLOGY OF EXTRACT - IN VITRO
INOTROPIC EFFECT POSITIVE
Citrus hassaku (RUTACEAE)
646772
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Citrus hassaku (RUTACEAE)
124955
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
CITRUSARIN A
869554
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
MARMIN
140931
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
AURAPTEN,EPOXY: (+):
971812
PHARMACOLOGY OF EXTRACT - IN VITROANTIFERTILITY
UTERINE RELAXATION EFFECT
Citrus hassaku (RUTACEAE)
140938
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
UMBELLIFERONE
521821
ISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
FLAVONE,3-3'-4'-5-6-7-8-HEPTAMETHOXY:
119253
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
SESELINOL ISO-VALERATE
439089
VOUCHER SPECIMEN REPORTED FOR
Citrus hassaku (RUTACEAE)
140935
PMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
COUMARIN,7-(3-7-DIMETHYL-8-OXO-OCTA-TRANS-2-TRANS-6-DIENYL-OXY):
869551
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
AURAPTEN,6'-7'-EPOXY:
531241
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHYPERTENSIVE ACTIVITY
Citrus hassaku (RUTACEAE)
646769
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Citrus hassaku (RUTACEAE)
140943
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
COUMARIN,7(6(R)-HYDROXY-7-METHOXY-3-7-DIMETHYL-OCT-TRANS-2-ENYL-OXY):
140950
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
FUROCOUMARIN,5-HYDROXY:
140932
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
MARMIN,(+):
1185213
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIFUNGAL ACTIVITY
Citrus hassaku (RUTACEAE)
AURAPTEN
119250
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
DENTATIN,NOR: OXA:
140947
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
COUMARIN,7-HYDROXY-6-LINALYL: (DL):
602883
QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS
Citrus hassaku (RUTACEAE)
SYNEPHRINE
140940
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
COUMARIN,7-(3-7-DIMETHYL-6-HYDROXY-OCTA-TRANS-2-TRANS-7(9)-DIENYL-OXY):
537316
ISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
APIGENIN-7-(2-O-ALPHA-RHAMNOSYL-BETA-D-GLUCOSIDE)PRUNIN
971813
PHARMACOLOGY OF EXTRACT - IN VITRO
ADRENERGIC AGONIST(BETA)
Citrus hassaku (RUTACEAE)
869552
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
AURAPTEN,6'-7'-EPOXY:
601529
PHARMACOLOGY OF EXTRACT - IN VITRO
LIPOXYGENASE INHIBITION
Citrus hassaku (RUTACEAE)
128622
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
AURAPTEN
1185212
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus hassaku (RUTACEAE)
AURAPTEN
521822
PHARMACOLOGY OF COMPOUND - IN VITRO
INOTROPIC EFFECT POSITIVE
Citrus hassaku (RUTACEAE)
FLAVONE,3-3'-4'-5-6-7-8-HEPTAMETHOXY:
172673
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
CLAUDIMERIN A
183809
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
CLAUDIMERIN A
222758
ISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
MEGASTIGMA-4-TRANS-7-DIEN-3-ONE-9-O-BETA-D-GLUCOSIDE,9-HYDROXY: (6R-9R):TERPINEOL,ALPHA: 8-BETA-D-GLUCOPYRANOSIDEVOMIFOLIOL-9-O-BETA-GLUCOPYRANOSIDELINALOOL,9-HYDROXY: 9-BETA-GLUCOPYRANOSIDECARVEOL-5-BETA-D-GLUCOPYRANOSIDE,TRANS:
128625
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
COUMARIN,7-(6(R)-HYDROXY-3-7-DIMETHYL-OCTA-TRANS-2-7-DIENYL-OXY):
152312
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
ACRIMARINE D,NEO:
935865
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Citrus hassaku (RUTACEAE)
HESPERIDIN,NEO:
128623
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
COUMARIN,7-HYDROXY-6-LINALYL: (DL):
1185211
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus hassaku (RUTACEAE)
AURAPTEN
152313
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
DECURSIDINOL,TRANS-5-METHOXY:
140937
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
UMBELLIFERONE
140948
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
COUMARIN,7-HYDROXY-6-LINALYL: (DL):
869549
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
AURAPTEN
123431
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
BISCLAUSARIN
971809
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTISPASMODIC ACTIVITY(UNSPECIFIED TYPE)
Citrus hassaku (RUTACEAE)
971810
PHARMACOLOGY OF EXTRACT - IN VIVO
DIURETIC ACTIVITY
Citrus hassaku (RUTACEAE)
140944
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
COUMARIN,7(6(R)-HYDROXY-7-METHOXY-3-7-DIMETHYL-OCT-TRANS-2-ENYL-OXY):
602882
QUANTITATIVE DATAIDENTIFICATION IN BY GC/MS
Citrus hassaku (RUTACEAE)
SYNEPHRINE
119251
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
CLAUSARIN,OXA:
140933
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
COUMARIN,7-(3-7-DIMETHYL-6-OXO-OCT-TRANS-2-ENYL-OXY):
646771
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Citrus hassaku (RUTACEAE)
208021
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
PONCITRIN,BIS-NOR:
140951
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
FUROCOUMARIN,5-GERANYL-OXY:
1185208
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
ANTIBACTERIAL ACTIVITY
Citrus hassaku (RUTACEAE)
AURAPTEN
439090
IDENTIFICATION IN BY HPLC
Citrus hassaku (RUTACEAE)
NOBILETINSINENSETINTANGERETIN
140936
PHARMACOLOGY OF COMPOUND - IN VITRO
SPASMOLYTIC ACTIVITY
Citrus hassaku (RUTACEAE)
COUMARIN,7-(3-7-DIMETHYL-8-OXO-OCTA-TRANS-2-TRANS-6-DIENYL-OXY):
646770
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Citrus hassaku (RUTACEAE)
152316
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
HASSANIDIN
935864
IDENTIFICATION IN BY HPLCQUANTITATIVE DATA
Citrus hassaku (RUTACEAE)
NARINGIN
141886
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
CITRUMARIN D
971818
PHARMACOLOGY OF EXTRACT - IN VITRO
ANTICHOLINERGIC ACTIVITY
Citrus hassaku (RUTACEAE)
646774
PHARMACOLOGY OF EXTRACT - IN VITRO
EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION
Citrus hassaku (RUTACEAE)
971822
PHARMACOLOGY OF EXTRACT - IN VITRO
CORONARY VASODILATOR ACTIVITY
Citrus hassaku (RUTACEAE)
869553
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Citrus hassaku (RUTACEAE)
MARMIN
971814
PHARMACOLOGY OF EXTRACT - IN VITRO
PLATELET AGGREGATION INHIBITION
Citrus hassaku (RUTACEAE)
169235
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Citrus hassaku (RUTACEAE)
FUROBICLAUSARIN